Human Chorionic Gonadotropin Test Market Share

  • Report ID: 3160
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Human Chorionic Gonadotropin Test Market Share

APAC Market Statistics

Geographically, the human chorionic gonadotropin (HCG) market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific industry is poised to dominate majority revenue share by 2036, owing to growing population, increasing concern and awareness among the individuals in the region.

North America Market Analysis

Furthermore, in 2021, the human chorionic gonadotropin (HCG) market in North America is evaluated to occupy the largest share in terms of revenue, owing to the increasing incidence of infertility among the women aged between 15-44 years in the region. According to the report published by the Centers for Disease Control and Prevention (CDC), annually approximately 10% of the women which accounts for 6.1 million in the United States face difficulty to conceive or staying pregnant. Such increasing issues during the reproductive age among the individuals and couples is further expected to drive the demand for Human chorionic gonadotropin (HCG) in the North American countries. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global Human chorionic gonadotropin (HCG) market on account of its proven success in terms of technology development in the region.

Research Nester
Human-Chorionic-Gonadotropin-Test-Market-Share
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3160
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising cases of infertility and increasing in the incidence of male hypogonadism are the key factors driving market growth.

The market is anticipated to attain a high CAGR over the forecast period, i.e., 2021-2029.

With respect to therapeutic area, the female infertility segment is anticipated to hold the largest market share owing to the growing number of infertility cases among the young women.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing population and infertility among individuals.

The major players dominating the Human Chorionic Gonadotropin (hCG) Test market are Merck & Co., Cigna, Lee BioSolutions, Swiss Precision Diagnostics GmbH, Abbott Laboratories, Quidel Corporation, Geratherm Medical AG, bioMérieux SA, CIGA Healthcare Ltd, and Others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample